genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
From the Bench to Benchling
Drug Discovery
Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Coronavirus
A ‘Patch’-Work Solution to Vaccine Delivery
Bioinformatics
NVIDIA Powers Up in Drug Discovery
News
Gene Therapy
Expanding Gene Therapy Presence, Bayer to Acquire AskBio for Up to…
Neuroscience
Discovery of New Immune Cell Type May Unlock Strategies against Neurological…
Translational Medicine
Human Airway Basal Stem Cells Created from Patients’ Cells
Coronavirus
CRISPR-Based Screen Identifies Host Factors for SARS-CoV-2 Infection
Antibodies
Cancer’s Spread Prevented by Blocking Signaling along the Lymphatic Route
Insights
All
Trends for 2020
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Contract Manufacturer Sets Up for Fill-and-Finish Next-Generation Therapies
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Bioprocessing
Ori Biotech Raises $30 Million in Financing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
Expanding Gene Therapy Presence, Bayer to Acquire AskBio for Up to…
Translational Medicine
Human Airway Basal Stem Cells Created from Patients’ Cells
Coronavirus
CRISPR-Based Screen Identifies Host Factors for SARS-CoV-2 Infection
Antibodies
Cancer’s Spread Prevented by Blocking Signaling along the Lymphatic Route
Magazine
October 2020 Vol. 40 No. 10
Spatial: The Next Omics Frontier
October 2020 Vol. 40 No. 10
Gene Therapy Startups Extend Biotech’s Legacy
October 2020 Vol. 40 No. 10
Viral or Nonviral: Which Is Better for CRISPR-Based Therapies?
October 2020 Vol. 40 No. 10
The Chronicles of CRISPR
October 2020 Vol. 40 No. 10
Host Cell Protein Analysis Informs Risk Assessment
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Janssen Biotech
Janssen Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Janssen Biotech
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
Janssen Biotech
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19 Vaccines
Janssen Biotech
J&J’s Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
Janssen Biotech
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Janssen Biotech
J&J Eyes September Trial for COVID-19 Vaccine, Commits to Expanded $1B+ BARDA Partnership
Janssen Biotech
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse...
Janssen Biotech
Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary...
Janssen Biotech
JLABS, Children’s National to Open Incubator, Collaborate on BARDA “Innovation Zone”...
Janssen Biotech
J&J Innovation Partners with AdoRx Therapeutics on Lung Cancer Treatments
Janssen Biotech
J&J’s Janssen to Develop MeiraGTx’s Retinal Disease Gene Therapies
Janssen Biotech
J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration
Janssen Biotech
Janssen Halts Clinical Studies of Alzheimer’s Candidate
Janssen Biotech
Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M
Janssen Biotech
Janssen to Codevelop Theravance’s TD-1473 in $1B+ Collaboration
Janssen Biotech
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
